“We are proud of the continued momentum building at Tourmaline, highlighted by the formation of our Cardiovascular Scientific Advisory ... Tourmaline presented a poster describing the rationale and ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

The poster will be presented at the American Heart Association (AHA) Scientific Sessions on November 16 ... statements in this press release include statements regarding: the design, objectives, ...

Targeted, better-tolerated oral PDE4 inhibitors are an unmet need in inflammatory bowel disease (IBD) PALI-2108 demonstrates in ex vivo studies; targeted activation and reduced side effects, ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS ®), today announced the acceptance of a poster titled "Noninvasive ... the largest worldwide ...

As we recently announced, Absci is collaborating with Twist to design a novel antibody using generative AI ... At this event, you will hear from our executive leadership and our scientific team as ...

allowing for control of tumors in vivo without the need for exogenous or engineered cytokines – – Posters include demonstration of advances in gene editing and transgene design that enable greater ...

The building used to be a boat-assembly plant, which made the festivities oddly apt, since tattoos have always thrived on ...

Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food ...

Q3 2024 Earnings Conference Call November 7, 2024 11:00 AM ETCompany ParticipantsKim Golodetz - Alliance Advisors ...

Differences in socioeconomic status during early pregnancy may explain the majority of the disparities in cardiovascular ...

Out-of-hospital cardiac arrest survival rates dropped significantly at the onset of the COVID-19 pandemic in 2020 and have ...